1. Home
  2. MESO vs NBHC Comparison

MESO vs NBHC Comparison

Compare MESO & NBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesoblast Limited

MESO

Mesoblast Limited

HOLD

Current Price

$11.96

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo National Bank Holdings Corporation

NBHC

National Bank Holdings Corporation

HOLD

Current Price

$37.53

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MESO
NBHC
Founded
2004
2009
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
2005
2011

Fundamental Metrics

Financial Performance
Metric
MESO
NBHC
Price
$11.96
$37.53
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$37.00
★ $44.00
AVG Volume (30 Days)
216.6K
★ 446.7K
Earning Date
08-26-2026
10-27-2026
Dividend Yield
N/A
★ 3.38%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 1.04
Revenue
N/A
★ $47,100,000.00
Revenue This Year
$59.17
$25.73
Revenue Next Year
$59.00
$7.50
P/E Ratio
★ N/A
$36.41
Revenue Growth
N/A
★ 2.86
52 Week Low
$12.94
$35.06
52 Week High
$21.50
$47.28

Technical Indicators

Market Signals
Indicator
MESO
NBHC
Relative Strength Index (RSI) 28.02 33.96
Support Level N/A $37.43
Resistance Level $15.97 $42.66
Average True Range (ATR) 0.40 0.67
MACD -0.12 0.03
Stochastic Oscillator 2.03 29.80

Price Performance

Historical Comparison
MESO
NBHC

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

About NBHC National Bank Holdings Corporation

National Bank Holdings Corp offers a full range of banking products and financial services to commercial, business, and consumer clients predominantly in Colorado, with a focus on personalized service through relationship managers and banking center associates. The company provides commercial and industrial loans, non-owner occupied commercial real estate loans, Small Business Administration loans as a Preferred Lender Provider, U.S. Department of Agriculture and Farm Service Agency loans, commercial deposit and treasury management products, business online and mobile banking, consumer and residential real estate loans, deposit services, and trust and wealth management services. Its services emphasize full-relationship banking, integrating lending, deposits, and cash management solutions.

Share on Social Networks: